CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients
CD25 阻断可消耗并选择性地重新编程调节性 T 细胞，与癌症患者的免疫疗法协同作用
期刊:Science Translational Medicine
影响因子:15.8
doi:10.1126/scitranslmed.3003330
Andrew J Rech, Rosemarie Mick, Sunil Martin, Adri Recio, Nicole A Aqui, Daniel J Powell Jr, Theresa A Colligon, Jennifer A Trosko, Leah I Leinbach, Charles H Pletcher, Carol K Tweed, Angela DeMichele, Kevin R Fox, Susan M Domchek, James L Riley, Robert H Vonderheide
